Terms: = Prostate cancer AND ERG, P11308, 2078
1233 results:
1. A cross-sectional study of erg expression and the relationship with clinicopathological features of prostate cancer in Southwestern Uganda.
Mitala Y; Ssenkumba B; Birungi A; Kiconco R; Mutakooha MM; Atwine R
Diagn Pathol; 2024 May; 19(1):67. PubMed ID: 38730435
[TBL] [Abstract] [Full Text] [Related]
2. Transcription Factors in prostate cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches.
Silva KCS; Tambwe N; Mahfouz DH; Wium M; Cacciatore S; Paccez JD; Zerbini LF
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674385
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.
Weiss S; Lamy P; Rusan M; Nørgaard M; Ulhøi BP; Knudsen M; Kassentoft CG; Farajzadeh L; Jensen JB; Pedersen JS; Borre M; Sørensen KD
Int J Cancer; 2024 Jul; 155(2):298-313. PubMed ID: 38602058
[TBL] [Abstract] [Full Text] [Related]
4. High-dose-rate Brachytherapy Monotherapy in Patients With Localised prostate cancer: Dose Modelling and Optimisation Using Computer Algorithms.
Dabic-Stankovic K; Rajkovic K; Stankovic J; Marosevic G; Kolarevic G; Pavicar B
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):378-389. PubMed ID: 38584072
[TBL] [Abstract] [Full Text] [Related]
5. Ductal Adenocarcinoma of the prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.
Zara Rozalen A; Martin JM; Rajendran R; Jain M; Nava VE
Curr Oncol; 2024 Mar; 31(3):1556-1561. PubMed ID: 38534951
[TBL] [Abstract] [Full Text] [Related]
6. Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles.
Ruzanov P; Evdokimova V; Pachva MC; Minkovich A; Zhang Z; Langman S; Gassmann H; Thiel U; Orlic-Milacic M; Zaidi SH; Peltekova V; Heisler LE; Sharma M; Cox ME; McKee TD; Zaidi M; Lapouble E; McPherson JD; Delattre O; Radvanyi L; Burdach SE; Stein LD; Sorensen PH
J Clin Invest; 2024 Mar; 134(9):. PubMed ID: 38530366
[TBL] [Abstract] [Full Text] [Related]
7. Amplification of different satellite-DNAs in prostate cancer.
Ariffen NA; Ornellas AA; Alves G; Shana'ah AM; Sharma S; Kankel S; Jamali E; Theis B; Liehr T
Pathol Res Pract; 2024 Apr; 256():155269. PubMed ID: 38522124
[TBL] [Abstract] [Full Text] [Related]
8. Effect of nonsteroidal anti-inflammatory drugs (aspirin and naproxen) on inflammation-associated proteomic profiles in mouse plasma and prostate during TMPRSS2-erg (fusion)-driven prostate carcinogenesis.
Prasad RR; Mishra N; Kant R; Fox JT; Shoemaker RH; Agarwal C; Raina K; Agarwal R
Mol Carcinog; 2024 Jun; 63(6):1188-1204. PubMed ID: 38506376
[TBL] [Abstract] [Full Text] [Related]
9. TP63-TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer.
Sultanov R; Mulyukina A; Zubkova O; Fedoseeva A; Bogomazova A; Klimina K; Larin A; Zatsepin T; Prikazchikova T; Lukina M; Bogomiakova M; Sharova E; Generozov E; Lagarkova M; Arapidi G
Epigenetics Chromatin; 2024 Mar; 17(1):6. PubMed ID: 38481282
[TBL] [Abstract] [Full Text] [Related]
10. Brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
11. Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations.
Hu J; Chen X; Sun F; Liu L; Liu L; Yang Z; Zhang H; Yu Z; Zhao R; Wang Y; Liu H; Yang X; Sun F; Han B
Neoplasia; 2024 Apr; 50():100983. PubMed ID: 38417222
[TBL] [Abstract] [Full Text] [Related]
12. Molecular complexity of intraductal carcinoma of the prostate.
Zhu S; Xu N; Zeng H
Cancer Med; 2024 Jan; 13(2):e6939. PubMed ID: 38379333
[TBL] [Abstract] [Full Text] [Related]
13. Individualized detection of TMPRSS2-erg fusion status in prostate cancer: a rank-based qualitative transcriptome signature.
Li Y; Su H; Liu K; Zhao Z; Wang Y; Chen B; Xia J; Yuan H; Huang DS; Gu Y
World J Surg Oncol; 2024 Feb; 22(1):49. PubMed ID: 38331878
[TBL] [Abstract] [Full Text] [Related]
14. Repeated prostate cancer Screening Using prostate-Specific Antigen Testing and Magnetic Resonance Imaging: A Secondary Analysis of the STHLM3-MRI Randomized Clinical Trial.
Nordström T; Annerstedt M; Glaessgen A; Carlsson S; Clements M; Abbadi A; Grönberg H; Jäderling F; Eklund M; Discacciati A
JAMA Netw Open; 2024 Feb; 7(2):e2354577. PubMed ID: 38324313
[TBL] [Abstract] [Full Text] [Related]
15. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:erg Fusion Status in prostate cancer Using Whole Slide Images.
Omar M; Xu Z; Rand SB; Alexanderani MK; Salles DC; Valencia I; Schaeffer EM; Robinson BD; Lotan TL; Loda M; Marchionni L
Mol Cancer Res; 2024 Apr; 22(4):347-359. PubMed ID: 38284821
[TBL] [Abstract] [Full Text] [Related]
16. PTEN, erg, SPINK1, and TFF3 Status and Relationship in a prostate cancer Cohort from Jordanian Arab Population.
Al Bashir S; Alorjani MS; Kheirallah K; Al Hamad M; Haddad HK; Al-Dwairy A; Bani-Fawwaz BA; Aldaoud N; Halalsheh O; Amawi S; Matalka II
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256434
[No Abstract] [Full Text] [Related]
17. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases.
Nguyen NJ; Sherman C; van der Kwast TH; Downes MR
Pathol Res Pract; 2024 Feb; 254():155105. PubMed ID: 38218041
[TBL] [Abstract] [Full Text] [Related]
18. cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progression.
Gulliver C; Busiau T; Byrne A; Findlay JE; Hoffmann R; Baillie GS
Mol Oncol; 2024 Mar; 18(3):707-725. PubMed ID: 38126155
[TBL] [Abstract] [Full Text] [Related]
19. FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of prostate cancer.
Dairo O; DePaula Oliveira L; Schaffer E; Vidotto T; Mendes AA; Lu J; Huynh SV; Hicks J; Sowalsky AG; De Marzo AM; Joshu CE; Hanratty B; Sfanos KS; Isaacs WB; Haffner MC; Lotan TL
Cancer Res Commun; 2024 Jan; 4(1):152-163. PubMed ID: 38112617
[TBL] [Abstract] [Full Text] [Related]
20. SND1 binds to erg and promotes tumor growth in genetic mouse models of prostate cancer.
Liao SY; Rudoy D; Frank SB; Phan LT; Klezovitch O; Kwan J; Coleman I; Haffner MC; Li D; Nelson PS; Emili A; Vasioukhin V
Nat Commun; 2023 Nov; 14(1):7435. PubMed ID: 37973913
[TBL] [Abstract] [Full Text] [Related]
[Next]
